Industry Briefs

New York Scientists Take French Partner Virogenetics, a newly opened vaccine research lab in Troy, N.Y., is an international marriage of scientific convenience - a partnership between a French vaccine manufacturer and a team of New York scientists from the state Health Department's Wadsworth Center for Laboratory and Research in Albany. Several years ago the New Yorkers, led by state research scientist Enzo Paoletti, developed a method, using recombinant DNA technology and the cowpox virus, tha

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

New York Scientists Take French Partner
Virogenetics, a newly opened vaccine research lab in Troy, N.Y., is an international marriage of scientific convenience - a partnership between a French vaccine manufacturer and a team of New York scientists from the state Health Department's Wadsworth Center for Laboratory and Research in Albany. Several years ago the New Yorkers, led by state research scientist Enzo Paoletti, developed a method, using recombinant DNA technology and the cowpox virus, that might eventually be used as a genetic carrier for immunizations against a number of diseases. With the technology in one hand and a U.S. patent in the other, the Health Department's nonprofit corporation, Health Research Inc., began courting vaccine manufacturers to bankroll R&D. Enter a most willing suitor, Institut Merieux, a worldwide leader in vaccine production with $400 million in sales last year.

The Lyon, France, company, which was founded in 1897 by a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies